Bing

SEARCH HISTORY

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Trade-Ideas LLC identified GlaxoSmithKline ( GSK) as a pre-market mover ...
The Street · 18 hours ago
GSK, the world's No. 7 drugmaker ... The company's trailing 12-month (TTM) EPS was at Rs 44.29 per share as per the quarter ended March 2015. The stock's price-to-earnings (P/E) ratio was 77.57. The latest book …
Money Control · 4 hours ago
earnings growth
Some of the biggest gainers among healthcare stocks include: Examworks Group (EXAM): EXAM stock is up 8.1% today. Glaxosmithkline Plc (GSK): GSK stock is up 2.6% today. Pfizer Inc (PFE): PFE stock is up 1.6% today. Wuxi Pharmatech …
Investor Place · 13 hours ago
Healthcare Stocks
More from Bing News
GlaxoSmithKline plc (LON:GSK)‘s stock had its “underperform” rating reiterated by analysts at Credit Suisse in a research report issued to clients and investors on Wednesday, AnalystRatings.Net reports. They currently have a GBX 1,440 ($22.35 ...
Ticker Report · 19 hours ago
GlaxoSmithKline plc
StockMarketWire.com - GlaxoSmithKline Capital - a wholly owned indirect subsidiary of GlaxoSmithKline plc - posts an after-tax profit of £4,061,000 for the six months to the end of June, up from £2,852,000. The company - which issues US and euro …
Stock Market Wire · 22 minutes ago
GSK Capital
GlaxoSmithKline’s second-quarter earnings slipped, but not as much as analysts had feared, encouraging investors and sending the pharmaceutical giant’s stock up 3.5 percent in mid-morning trading. In its first earnings report since completing a $20 ...
The News & Observer · ByJohn Murawski · 15 hours ago
(GSK.L, GSK), reported a drop in profit for the second quarter ... our targets for this year and return the Group to earnings growth in 2016." On the London Stock Exchange, Glaxo is trading at 1,374.50 pence, up 46.00 pounds or 3.46%.
NASDAQ · 14 hours ago
Profit
GlaxoSmithKline (GSK - Analyst Report), one of the largest healthcare companies, reshaped its business following the Mar 2015 completion of the three-part, inter-conditional transaction with Novartis related to its Consumer Healthcare, Vaccines and ...
ZACKS · 19 hours ago
Earnings
GlaxoSmithKline plc (LON:GSK)‘s stock had its “buy” rating restated by AlphaValue in a research note issued on Thursday, Market Beat reports. They currently have a GBX 1,732 ($27.03) price objective on the stock. AlphaValue’s price objective …
sleekmoney.com · 7/23/2015
GlaxoSmithKline plc (LON:GSK)‘s stock had its “buy” rating reiterated by analysts at Goldman Sachs in a research report issued to clients and investors on Friday, MarketBeat.com reports. They currently have a GBX 1,800 ($27.91) price target on the …
wkrb13.com · 7/18/2015

GlaxoSmithKline

Company
GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. It was the world'…
GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. It was the world's sixth-largest pharmaceutical company in 2014, after Pfizer, Novartis, Sanofi, Hoffmann-La Roche and Merck. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham.
Data from: Wikipedia